|
| CYTOCHALASIN D Basic information |
Product Name: | CYTOCHALASIN D | Synonyms: | CYTOCHALASIN D;CYTOCHALASIN D, ZYGOSPORIUM MANSONII;CYTOCHALASIN D, ZYGUSPORIUM MANSONII;(7S,13E,16S,18R,19E,21R)-21-(ACETYLOXY)-7,18-DIHYDROXY-16,18-DIMETHYL-10-PHENYL[11]CYTOCHALASA-6(12),13,19-TRIENE-1,17-DIONE;(11)cytochalasa-6(12),13,19-triene-1,17-dione,21-(acetyloxy)-7,18-dihydroxy-16;,12,15-decahydro-6,12,15-trihydroxy-4,10,12-trimethyl-5-methylene-,15-acetate;,18-dimethyl-10-phenyl-,(7s,13e,16s,18r,19e,21r)-;15-decahydro-6,12,15-trihydroxy-4,10,12-trimethyl-5-methylene-115-acetate | CAS: | 22144-77-0 | MF: | C30H37NO6 | MW: | 507.62 | EINECS: | 244-804-1 | Product Categories: | antibiotic;Caspases/Apoptosis | Mol File: | 22144-77-0.mol | |
| CYTOCHALASIN D Chemical Properties |
Melting point | 255-260°C | Boiling point | 595.84°C (rough estimate) | density | 1.1764 (rough estimate) | refractive index | 1.6310 (estimate) | Fp | 87℃ | storage temp. | −20°C | solubility | DMSO: soluble | pka | 11.95±0.70(Predicted) | form | White solid | color | White | BRN | 1632828 | Stability: | Stable for 2 years from date of purchase as supplied. Solutions in DMSO or ethanol may be stored at -20° for up to 3 months. | LogP | 2.640 (est) | EPA Substance Registry System | Cytochalasin D (22144-77-0) |
| CYTOCHALASIN D Usage And Synthesis |
Description | Cytochalasin D (22144-77-0) is a potent inhibitor of actin polymerization which also causes the disruption of actin filaments. More potent that cytochalasin B (10-fold) and does not inhibit monosaccharide transport across cell membranes. Disruption of actin microfilaments leads to activation of p53. Cell permeable | Chemical Properties | Powder | Uses | A cell cycle arresting compound used in actin polymerization studies and cytological research | Uses | Cytochalasin D is the most studied of the cytochalasins. Like most of the members of this mycotoxin class, cytochalasin D exhibits potent inhibition of actin filament function leading to cell death by apoptosis. This led to early investigation of the metabolite as an antitumour agent. Cytochalasin D has become one of the standard cellular probes for investigating the role of actin in cell biology. | Uses | Cytochalasin D acts as an anti-hypertensive drug acting on human intestinal epithelial caco-2 cells. Also has activity in HMG-CoA reductase inhibitors used in the lowering of cholesterol. Actin inhib
itor, actin polymerization inhibitor affecting cell movement, growth, phagocytosis and even secretion. | Definition | ChEBI: An organic heterotricyclic compound that is a mycotoxin produced by Helminthosporium and other moulds which is cell permeable and a potent inhibitor of actin polymerisation and DNA synthesis. | General Description | Needles or fluffy white powder. | Reactivity Profile | CYTOCHALASIN D may be sensitive to exposure to heat. CYTOCHALASIN D can react with strong oxidizing agents, strong acids and strong bases. . | Fire Hazard | Flash point data for CYTOCHALASIN D are not available; however, CYTOCHALASIN D is probably combustible. | Biological Activity | Potent disruptor of actin filament function. Alters tight junction permeability. Unlike cytochalasin B, does not inhibit monosaccharide transport across the plasma membrane. | Biochem/physiol Actions | Cell permeable fungal toxin; potent inhibitor of actin polymerization. Disrupts actin microfilaments and activates the p53-dependent pathways causing arrest of the cell cycle at the G1-S transition. Inhibits smooth muscle contraction. Inhibits insulin-stimulated, but not basal, transport of glucose. | Safety Profile | Poison by ingestion,
subcutaneous, and intraperitoneal routes. An
experimental teratogen. Experimental
reproductive effects. Human mutation data
reported. When heated to decomposition it
emits toxic fumes of NOx. | target | p38MAPK | PI3K | Akt | Calcium Channel | ATPase | storage | Store at -20°C | References | 1)) Goddetteand et al. (1986), Actin polymerization. The mechanism of action of cytochalasin D; J. Biol. Chem., 261 15974
2) Rubtsova et al. (1998), Disruption of actin microfilaments by cytochalasin D leads to activation of p53; FEBS Lett., 430 353 |
| CYTOCHALASIN D Preparation Products And Raw materials |
|